2 C) compared to radiation dose < 50 Gy (15.0 vs 6.3 months, p < 0.01), though only a clear trend of benefit instead of significance was observed in OS ( Fig. 2 D).
← all excerpts
The value of intervention with radiotherapy after first-line chemo-immunotherapy in locally advanced or metastatic esophageal squamous cell carcinoma: A multi-center retrospective study.
1
—
—